ledaborbactam etzadroxil

DRUG2 trials

Sponsors

Basilea Pharmaceutica

Conditions

Drug-Drug Interaction (DDI)FDCHealthy VolunteerHealthy VolunteersPharmacokineticsSafety

Phase 1

Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age

CompletedNCT06665555

Basilea PharmaceuticaHealthy Volunteers, Pharmacokinetics

Start: 2024-11-04End: 2025-03-17Updated: 2026-01-23

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

RecruitingNCT06733675

Basilea PharmaceuticaDrug-Drug Interaction (DDI), FDC, Healthy Volunteer +2

Start: 2025-01-07End: 2026-12-30Target: 96Updated: 2026-07-09

Related Papers

Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults.

2026-04-20